Author Correction: Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: Inhibition of TRIP-Br2, a key modulator of lipid breakdown, thermogenic activity, and oxidative processes, mitigates obesity and insulin resistance linked to diet.

  • By

  • Chong Wee Liew

  • Jeremie Boucher

  • Jit Kong Cheong

  • Cecile Vernochet

  • Ho-Jin Koh

  • Cristina Mallol

  • Kristy Townsend

  • Dominique Langin

  • Dan Kawamori

  • Jiang Hu

  • Yu-Hua Tseng

  • Marc K Hellerstein

  • Stephen R Farmer

  • Laurie Goodyear

  • Alessandro Doria

  • Matthias Blüher

  • Stephen I-Hong Hsu

  • Rohit N Kulkarni

  • September 9, 2026

Share

  • 1

    A correction notice was published online on 6 January 2013 for a Nature Medicine article.

  • 2

    The protein plot in Supplementary Fig. 3a was corrected from 'Epi/HF' to 'SQ/HF'.

  • 3

    Supplementary Fig. 12c was amended due to incorrect oil-red-O-stained images.

  • 4

    The corrected figures are included in the revised Supplementary Information.

  • 5

    The DOI for the correction notice is 10.1038/nm.3056.

Original Source(s)

Related Content